ASB -9.01%: The shipbuilder that we recently added to in our Emerging Companies portfolio downgraded today by ~8% and the stock fell a similar amount. They blamed COVID for delays which will result in revenue for FY21 being $1.55b instead of the $1.65b they expected which means earnings (EBIT) will be $112-$118m, a $10m downgrade relative to current market expectations of $125m. While the news is clearly a negative, in a situation like this we review our thesis to see if it remains intact, and in this case it does. We’re expecting more uncertainty in the short term around earnings however we’re of the view that this presents a medium term opportunity as they push into steel shipbuilding with the support of the US Navy.
scroll
Question asked
Question asked
Question asked
Question asked
Question asked
Question asked
Performance update for March, stocks that drove returns & our current positioning
Close
Friday 26th April – ASX200 -101pts, Newmont (NEM), Resmed (RMD) & Super Retail (SUL)
Close
Market Matters Research Lead Shawn Hickman with David Koch
Close
MM remains positive ASB although patience required
Add To Hit List
Related Q&A
Thoughts towards Austal (ASB)
Thoughts on ASB after its downgrade?
Thoughts on Capitol Health, Austal and Standline Resources?
Austal (ASB) – is it a buy?
Is Austal a takeover target?
Austal (ASB) share price decline
Relevant suggested news and content from the site
Video
WATCH
Performance update for March, stocks that drove returns & our current positioning
Recorded Tuesday 9th April
Podcast
LISTEN
Friday 26th April – ASX200 -101pts, Newmont (NEM), Resmed (RMD) & Super Retail (SUL)
Daily Podcast Direct from the Desk
Video
WATCH
Market Matters Research Lead Shawn Hickman with David Koch
Recorded Monday 25th March
Members only
UNLOCK MARKET MATTERS NOW
Take a free trial.
No payment details required.